GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (NAS:IMCC) » Definitions » Institutional Ownership

IMCC (IM Cannabis) Institutional Ownership : 3.91% (As of Apr. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is IM Cannabis Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IM Cannabis's institutional ownership is 3.91%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IM Cannabis's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IM Cannabis's Float Percentage Of Total Shares Outstanding is 84.37%.


IM Cannabis Institutional Ownership Historical Data

The historical data trend for IM Cannabis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Institutional Ownership Chart

IM Cannabis Historical Data

The historical data trend for IM Cannabis can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 4.69 4.95 5.13 4.69 4.69 3.39 3.41 3.41 3.41 3.41

IM Cannabis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


IM Cannabis Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.